Invention Grant
- Patent Title: Thermostable blunt-end ligase and methods of use
- Patent Title (中): 热稳定性连接酶及其使用方法
-
Application No.: US14214834Application Date: 2014-03-15
-
Publication No.: US09273301B2Publication Date: 2016-03-01
- Inventor: Frederick Christians
- Applicant: Theranos, Inc.
- Applicant Address: US CA Palo Alto
- Assignee: Theranos, Inc.
- Current Assignee: Theranos, Inc.
- Current Assignee Address: US CA Palo Alto
- Main IPC: C12N9/00
- IPC: C12N9/00 ; C12P19/34

Abstract:
Fusion proteins having thermostable blunt-end ligase activity are provided. Blunt-end ligases are useful for DNA amplification, sequencing, production of recombinant DNA and recombinant fusion proteins, and other purposes. These thermostable blunt-end DNA ligases are useful in ligation schemes which include, e.g., an incubation at about 60-65° C. or higher, or as high as about 94° C., or at other temperatures. The ligases disclosed herein may enable high temperature blunt-end ligation without need for molecular crowding agents, and so may be useful for many nucleic acid ligation-amplification schemes, e.g., ones which operate at a uniform temperature (e.g., at about 60° C. or higher), including ones which require temperature cycling, e.g., from about 94° C. to about 60° C. (or higher) for one, two, three, or more cycles. The thermostable blunt-end DNA ligases disclosed herein enable higher specificity target amplification, for example, by permitting temperature denaturation of double-stranded DNA templates as well as specific primer binding.
Public/Granted literature
- US20140273102A1 THERMOSTABLE BLUNT-END LIGASE AND METHODS OF USE Public/Granted day:2014-09-18
Information query